Off-label utilization of antidepressants.

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Pharmacy

Background:

• Antidepressant prescription guidelines are established for approved indications.
• Off-label antidepressant use often lacks large-scale validation, relying on expert consensus.
• Understanding current prescription habits is crucial for optimizing patient care.

Purpose of the Study:

• To investigate hospital psychiatrists' antidepressant prescription habits.
• To compare prescribing patterns for depression and anxiety disorders versus off-label antidepressant use.
• To identify factors influencing antidepressant selection, dosing, and comedication.

Main Methods:

• A survey of drug use was conducted over 6 reference days (April 1999 - November 2001).
• Data were collected from 174 patients at a 98-bed psychiatric hospital in Lausanne, Switzerland.
• Prescriptions for patients with depressive disorders, anxiety disorders, and off-label indications were assessed.

Main Results:

• Diagnosis did not influence the choice between newer or older antidepressants.
• Patients with anxiety disorders were 4.5 times more likely to receive antipsychotic comedication compared to those with depressive disorders.
• Off-label indications were preferentially treated with lower antidepressant doses and less likely to involve older antidepressants when nonbenzodiazepine hypnotics were used concurrently.

Conclusions:

• Hospital psychiatrists exhibit preferences for specific antidepressant classes for both approved and off-label uses.
• Dose and comedication strategies are adapted based on the patient's diagnosis.
• These findings suggest physician-driven preferences influence antidepressant prescribing in clinical practice.